[Double blind randomized comparative study of two antihypertensive combinations. Enalapril-hydrochlorothiazide versus enalapril-nifedipine in 240 hypertensive patients resistant to monotherapy].

Author: ChastangC, ChazelleF, FrancesY, LafayV, MadonaO, SouchetT

Paper Details 
Original Abstract of the Article :
The combination of two antihypertensive drugs is recommended when mild to moderate hypertension is not controlled by sequential monotherapy. The aim of our study was to compare the efficacy and the safety of the combination enalapril 20 mg-hydrochlorothiazide 12.5 mg to that of enalapril 20 mg-nifed...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8762218

データ提供:米国国立医学図書館(NLM)

Comparing Antihypertensive Combinations: A Double-Blind Study

The quest for effective blood pressure control in patients with hypertension is like finding a hidden oasis in a vast desert. This research dives into the realm of antihypertensive therapies, exploring the efficacy and safety of combining enalapril with either hydrochlorothiazide or nifedipine in patients whose high blood pressure stubbornly resisted single-drug treatment.

The authors employed a double-blind, randomized controlled trial, a method as precise as a compass guiding a caravan through the dunes. They compared the two combination therapies in 240 individuals who had not experienced satisfactory blood pressure reduction with enalapril alone. The results revealed that both enalapril-hydrochlorothiazide and enalapril-nifedipine effectively lowered blood pressure, with similar reductions in diastolic blood pressure. However, the enalapril-hydrochlorothiazide group reported fewer side effects, suggesting a potential advantage in terms of tolerability.

The Importance of Finding the Right Combination

This study sheds light on the importance of tailoring antihypertensive therapy to the individual patient, much like choosing the right camel for a long journey. The study found that both combinations were effective, but enalapril-hydrochlorothiazide emerged as the more tolerable option. These results suggest that physicians should carefully consider the potential side effects of different antihypertensive drug combinations when making treatment decisions.

Navigating the World of Antihypertensive Therapies

Finding the right antihypertensive treatment can be challenging. It's like seeking the perfect balance between the hot sun and the cool shade of an oasis. This study provides valuable insights into the world of antihypertensive therapy, emphasizing the importance of considering both efficacy and safety. By carefully selecting the appropriate drug combination, healthcare providers can help patients achieve optimal blood pressure control and improve their overall well-being.

Dr. Camel's Conclusion

This study is like a refreshing well in the desert, offering valuable information about the efficacy and safety of different antihypertensive combinations. The results highlight the importance of finding the right balance between efficacy and tolerability when treating hypertension. The study's findings serve as a reminder that the journey to optimal blood pressure control often requires a careful and personalized approach, like choosing the right path through a vast and unforgiving desert.

Date :
  1. Date Completed 1996-10-24
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8762218

DOI: Digital Object Identifier

8762218

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.